Equitable Holdings’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$416K Sell
3,516
-44
-1% -$4.76K ﹤0.01% 1403
2026
Q1
$372K Sell
3,560
-175
-5% -$18.5K ﹤0.01% 1372
2025
Q4
$390K Buy
3,735
+219
+6% +$22K ﹤0.01% 1207
2025
Q3
$325K Buy
3,516
+61
+2% +$5.34K ﹤0.01% 1223
2025
Q2
$276K Buy
+3,455
New +$276K ﹤0.01% 1223
2024
Q1
Sell
-3,200
Closed -$243K 1195
2023
Q4
$243K Buy
+3,200
New +$229K ﹤0.01% 1002
2023
Q3
Sell
-2,686
Closed -$203K 1095
2023
Q2
$203K Buy
+2,686
New +$205K ﹤0.01% 985

Other funds holding PJP

Equitable Holdings's PJP Position: Q2 2026 in Review

Equitable Holdings reduced its Invesco Pharmaceuticals ETF (PJP) stake by 1.2% in Q2 2026, selling an estimated $4.76K and leaving 3,516 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Equitable Holdings first reported a position in PJP in Q2 2023 and has held it in 7 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Equitable Holdings held 3,516 shares of Invesco Pharmaceuticals ETF worth $416K as of Q2 2026.
  • Equitable Holdings sold 44 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $4.76K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1403 holding.
  • Equitable Holdings first reported a position in Invesco Pharmaceuticals ETF in Q2 2023 and has held it in 7 quarters since.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.